Sau et al. 2006 |
Retrospective cohort study |
Retrospective
cohort study |
Single-center |
≥ 24 weeks |
60 |
Not defined |
Not
defined |
No |
5-min Apgar score, umbilical pH, RDS, mortality,
ventilation |
- (-) |
(-) |
Differences in composite morbidity not
defined |
Hack et al. 2011
|
Secondary analysis of a retrospective cohort study
|
Secondary analysis of a retrospective cohort study
|
Multicenter
|
≥ 32 weeks
|
902
|
752
|
150
|
No
|
5-min Apgar score, pH, RDS, IUFD, mortality
|
2.0 (1.0-4.2)
|
(-)
|
No significant differences between:
- TOL vs. Planned CS
|
Hoffmann et al. 2012
|
Retrospective cohort study
|
Retrospective cohort study
|
Multicenter
|
36 weeks
|
115
|
63
|
52
|
No
|
5-min Apgar score, pH, mortality
|
0.9 (0.3-3.0)
|
0.83
|
No significant differences between:
- TOL vs. Planned CS
|
Weisz et al. 2012
|
Retrospective cohort study
|
Retrospective cohort study
|
Single-center
|
35+0-37+6 weeks
|
89
|
38
|
511
|
No (only in average of vaginal delivery, not morbidity)
|
5-min Apgar score, pH, RDS, sepsis, CNS, mortality
|
- (-)
|
0.24
|
No significant differences between:
- TOL vs. Planned CS
|
Yamashita et al. 2014 |
Retrospective cohort study |
Retrospective cohort study |
Single-center |
≥ 36 weeks |
295 |
187 |
108 |
No |
5-min Apgar scores < 7, IUFD after 36 weeks’
gestation, neonatal death, umbilical artery pH < 7.1, hypoxic
ischemic encephalopathy, meconium aspiration syndrome, respiratory
distress syndrome, or acute feto-fetal hemorrhage |
0.4 (0.1-2.0) |
0.29 |
No differences between TOL vs. Planned CS (univariate analysis of
perinatal factors for the composite adverse outcome, but no comparation
between groups) |
Ylilehto et al. 2017
|
Secondary analysis of a retrospective cohort study
|
Secondary analysis of a retrospective cohort study
|
Single-center
|
≥ 37 weeks
|
73
|
59
|
14
|
No
|
5-min Apgar < 4, 5-min Apgar < 7, umbilical artery
pH < 7.05 Y < 7.00, NICU admission
|
- (-)
|
>0.99
|
No significant differences between:
- TOL vs. Planned CS
|
Ylilehto et al. 2020
|
Secondary analysis of a retrospective cohort study
|
Secondary analysis of a retrospective cohort study
|
Single-center
|
Not specified to this cohort (primary cohort – mono and dichorionic:
32+0– 36+6 weeks of gestation)
|
55
|
40
|
15
|
No
|
5-min Apgar < 4, 5-min Apgar < 7, umbilical artery
pH < 7.05, NICU admission, intracerebral hemorrhage gr.
III-IV, respiratory morbidity, composite neonatal morbidity,
|
- (-)
|
0.18
|
No significant differences between:
- TOL vs. Planned CS
|
Aviram et al. 2020
|
Secondary analysis of a randomized, controlled trial
(Twin Birth Study, Barret et al. 2013)
|
Secondary analysis of a randomized, controlled trial
(Twin Birth Study, Barret et al. 2013)
|
Multicenter
|
32+0– 37+6 weeks
|
670
|
324
|
346
|
No
|
5-min Apgar < 4, Stillborn, neonatal death, primary, ,
umbilical artery pH < 7.0, NICU admission > 48h,
assisted ventilation, NEC, PVL, composite outcome
|
- (-)
|
0.25
|
No significant differences between:
- TOL vs. Planned CS
- Twin A vs. Twin B
- Monochorionic vs. Dichorionic
|